Novartis AG
XBER:NOT
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
N
|
Novartis AG
XBER:NOT
|
CH |
|
M
|
Mitsui Fudosan Co Ltd
XMUN:MFU
|
JP |
|
Fresenius Medical Care AG & Co KGaA
NYSE:FMS
|
DE |
|
F
|
Fabrinet
SWB:FAN
|
US |
|
G
|
General Mills Inc
XMUN:GRM
|
US |
Wall St Price Targets
NOT Price Targets Summary
Novartis AG
According to Wall Street analysts, the average 1-year price target for NOT is 85.57 EUR with a low forecast of 65.05 EUR and a high forecast of 102.15 EUR.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NOT's stock price target?
Price Target
85.57
EUR
According to Wall Street analysts, the average 1-year price target for NOT is 85.57 EUR with a low forecast of 65.05 EUR and a high forecast of 102.15 EUR.
What is the Revenue forecast for Novartis AG?
Projected CAGR
2%
Over the last 13 years, the compound annual growth rate for Revenue has been 0%. The projected CAGR for the next 8 years is 2%.
What is the Operating Income forecast for Novartis AG?
Projected CAGR
4%
Over the last 13 years, the compound annual growth rate for Operating Income has been 4%. The projected CAGR for the next 8 years is 4%.
What is the Net Income forecast for Novartis AG?
Projected CAGR
5%
Over the last 13 years, the compound annual growth rate for Net Income has been 3%. The projected CAGR for the next 8 years is 5%.
